COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,082 Articles (22,658 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 1020: Articles 10191-10200  | Next

SIR model for assessing the impact of the advent of Omicron and mitigating measures on infection pressure and hospitalization needs
van wees, j.-d., van der Kuip, M., Osinga, S., Keijser, B., Van Westerloo, D., Hanegraaf, M., Pluymaekers, M., Leeuwenburgh, O., Brunner, L., Tutu-van Furth, M.
10.1101/2021.12.25.21268394 — Posted: 2021-12-27
Temporal trends in hospitalizations and 30-day mortality in older patients during the COVID pandemic from March 2020 to July 2021
Garcia-Ptacek, S., Xu, H., Annetorp, M., Back Jerlardtz, V., Cederholm, T., Engstrom, M., Kivipelto, M., Lundberg, L. G., Metzner, C., Olsson, M., Skogo Nyvang, J., Suhl Oberg, C., Akesson, E., Religa, D., Eriksdotter, M.
10.1101/2021.12.22.21268237 — Posted: 2021-12-27
mRNA-1273 vaccination protects against SARS-CoV-2 elicited lung inflammation in non-human primates
Waickman, A. T., Victor, K., Newell, K. L., Li, T. L., Friberg, H., Foulds, K., Roederer, M., Bolton, D. L., Currier, J. R., Seder, R.
10.1101/2021.12.24.474132 — Posted: 2021-12-27
Estimating the impact of implementation and timing of COVID-19 vaccination program in Brazil: a counterfactual analysis
Ferreira, L. S., Marquitti, F. M. D., da Silva, R. L. P., Borges, M. E., Gomes, M. F. C., Cruz, O. G., Kraenkel, R. A., Coutinho, R. M., Prado, P. I., Bastos, L. S.
10.1101/2021.12.24.21268384 — Posted: 2021-12-27
Early Computational Detection of Potential High Risk SARS-CoV-2 Variants
Beguir, K., Skwark, M. J., Fu, Y., Pierrot, T., Lopez Carranza, S. N., Laterre, A., Kadri, I., Lui, B. G., Sanger, B., Liu, Y., Poran, A., Muik, A., Sahin, U.
10.1101/2021.12.24.474095 — Posted: 2021-12-27
Clinical grade ACE2 effectively inhibits SARS-CoV-2 Omicron infections
Monteil, V., Devignot, S., Klingstroem, J., Thalin, C., Kellner, M. J., Christ, W., Havervall, S., Mereiter, S., Knapp, S., Montserrat, N., Braunsfeld, B., Kozieradzki, I., Ali, O. H., Hagelkrueys, A., Stadlmann, J., Oostenbrink, C., Wirnsberger, G., Penninger, J. M., Mirazimi, A.
10.1101/2021.12.25.474113 — Posted: 2021-12-27
Impacts of the COVID-19 Pandemic on a Human Research Islet Program
Dafoe, T. J., dos Santos, T., Spigelman, A. F., Lyon, J., Smith, N., Bautista, A., MacDonald, P. E., Manning Fox, J. E.
10.1101/2021.12.24.474114 — Posted: 2021-12-27
Rapid selection of P323L in the SARS-CoV-2 polymerase (NSP12) in humans and non-human primate models and confers a large plaque phenotype
Dong, X., Goldswain, H., Penrice-Randal, R., Shawli, G., Prince, T., Williamson, M. K., Randle, N., Jones, B., Salguero, F. J., Tree, J., Hall, Y., Hartley, C., Erdmann, M., Bazire, J., Jearanaiwitayakul, T., ISARIC4C investigators, , Semple, M. G., Openshaw, P., Baillie, J. K., Emmett, S. R., Digard, P., Matthews, D. A., Turtle, L., Darby, A., Davidson, A. D., Carroll, M., Hiscox, J. A.
10.1101/2021.12.23.474030 — Posted: 2021-12-27
The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters
Abdelnabi, R., Foo, C. S.-Y., Zhang, X., Lemmens, V., Maes, P., Slechten, B., Raymenants, J., Andre, E., Weynand, B., Dallmeier, K., Neyts, J.
10.1101/2021.12.24.474086 — Posted: 2021-12-26
A subset of Memory B-derived antibody repertoire from 3-dose vaccinees is ultrapotent against diverse and highly transmissible SARS-CoV-2 variants, including Omicron
Wang, K., Jia, Z., Bao, L., Wang, L., Cao, L., Chi, H., Hu, Y., Li, Q., Jiang, Y., Zhu, Q., Deng, Y., Liu, P., Wang, N., Wang, L., Liu, M., Li, Y., Zhu, B., Fan, K., Fu, W., Yang, P., Pei, X., Cui, Z., Qin, L., Ge, P., Wu, J., Liu, S., Chen, Y., Huang, W., Qin, C., Wang, Y., Qin, C., Wang, X.
10.1101/2021.12.24.474084 — Posted: 2021-12-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).